Pleiotropic effects of statins
Statins or 3-hydroxy-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors not only prevents the synthesis of cholesterol biosynthesis but also inhibits the synthesis of essential isoprenoid intermediates such as farnesyl pyrophosphate, geranylgeranyl pyrophosphate, isopentanyl adenosine, dolicho...
Main Authors: | Narasaraju Kavalipati, Jay Shah, Ananthraman Ramakrishan, Hardik Vasnawala |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2015;volume=19;issue=5;spage=554;epage=562;aulast=Kavalipati |
Similar Items
-
Clinical, lipid-lowering, and pleiotropic effectiveness of rosuvastatin: a review of the GALAXY programme results
by: A. N. Britov, et al.
Published: (2011-02-01) -
Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon?
by: I. A. Latfullin, et al.
Published: (2015-12-01) -
Pleiotropic effects of statins: A boulevard to cardioprotection
by: Ankur Rohilla, et al.
Published: (2016-09-01) -
Efficacy and safety of the intensive dose of rosuvastatin 40 mg/day in patients with acute coronary syndrome and at high risk of cardiovascular disease-ROSUVEES-2
by: Chetan P. Shah, et al.
Published: (2016-11-01) -
Short- and long-term effects on reproductive parameters of female Wistar rats after exposure to rosuvastatin starting in pre-puberty
by: Jorge W.F. Barros, et al.
Published: (2020-06-01)